In a letter today, AHA again urged the Center for Medicare & Medicaid Innovation to delay the start date for its new radiation oncology alternative payment model until Jan. 1, 2022. The complex model, which will be mandatory in certain areas of the country and for which many details are still forthcoming, “would be difficult to implement in three months in the best of circumstances; it will be nearly impossible to implement in three months during a public health emergency,” AHA wrote.

AHA also urged CMMI to reconsider sudden changes to the Bundled Payments for Care Improvement Advanced model effective Jan. 1, especially the move to clinical episode service line groups. “Requiring model participants to take on risk for large, diverse bundles of episodes — instead of allowing them to choose individual episodes as is current policy — will require more financial risk than many participants can currently bear,” AHA wrote. It urged the agency at least to delay the changes for a year so participants can model their impact before having to make participation decisions.  

Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…